Literature DB >> 1939510

Diagnosis of measles by fluorescent antibody and culture of nasopharyngeal secretions.

M F Smaron1, E Saxon, L Wood, C McCarthy, J A Morello.   

Abstract

An indirect fluorescent antibody test (IFA) was evaluated using commercial mouse anti-measles monoclonal antibody and FITC-labeled goat anti-mouse immunoglobulin. For measles isolation, specimens were inoculated into Rhesus monkey kidney (RMK) cells and, when available, CV-1 cells. 381 specimens were tested by IFA and 408 specimens were cultured from patients suspected of having measles. For the 381 specimens tested by both methods, IFA and culture were positive for 31%, culture alone for 14%, IFA alone for 15%, and both negative for 40%. This study indicates that both IFA and culture are required for maximum measles virus detection. Of the positive specimens, 48% were detected either by IFA only (24%) or culture only (24%). IFA was positive in 69% of the culture-positive specimens and therefore, provided rapid diagnosis for many patients.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1939510     DOI: 10.1016/0166-0934(91)90022-r

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  3 in total

1.  Limited in vivo production of type I or type III interferon after infection of macaques with vaccine or wild-type strains of measles virus.

Authors:  Rupak Shivakoti; Debra Hauer; Robert J Adams; Wen-Hsuan W Lin; William Paul Duprex; Rik L de Swart; Diane E Griffin
Journal:  J Interferon Cytokine Res       Date:  2014-12-17       Impact factor: 2.607

2.  Polymerase chain reaction for detection of measles virus in clinical samples.

Authors:  H Shimizu; C A McCarthy; M F Smaron; J C Burns
Journal:  J Clin Microbiol       Date:  1993-05       Impact factor: 5.948

3.  Immature CD4+CD8+ thymocytes are preferentially infected by measles virus in human thymic organ cultures.

Authors:  Yukari Okamoto; Luca A Vricella; William J Moss; Diane E Griffin
Journal:  PLoS One       Date:  2012-09-24       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.